004 Perfusion mapping in hypertrophic cardiomyopathy: microvascular dysfunction occurs regardless of hypertrophy

Aims Patients with hypertrophic cardiomyopathy (HCM) histologically have myocyte hypertrophy and disarray, small vessel disease and fibrosis. The links and sequencing of these abnormalities in phenotype development is unclear. We implemented in-line perfusion mapping in HCM undergoing stress cardiovascular resonance (CMR) and measured pixel by pixel flow at stress and rest, in order to exactly quantify the microvascular dysfunction. Methods 30 HCM patients and 10 controls, age and gender-matched, referred for stress CMR due to atypical chest pain and having normal findings, underwent adenosine stress perfusion CMR using in-line perfusion mapping in Gadgetron to deliver pixel-by-pixel myocardial blood flow (MBF, mls/g/min) for three short axis views (± an additional long axis) at stress and rest. Transmural (tmMBF), endocardial (endoMBF) and epicardial (epiMBF) were calculated for each LV segment Figure). MBF was correlated with segmental wall thickness (WT) and late gadolinium enhancement (LGE), quantified by the 5 SD method. Results Stress MBF was lower in HCM (2.23±0.74 vs 3.49±0.82 mL/g/min, p 0.008 for tmMBF). This was most marked for endoMBF. The reductions were associated with increasing wall thickness (endoMBF R: –0.43, p Conclusion Perfusion mapping confirms that HCM patients have reduced MPR that is linked to wall thickness and scar. Stress flow can be lower than rest in hypertrophied segments. Apparently normal segments (no LVH, no LGE) have abnormal MBF suggesting this may be an early marker of the HCM phenotype. Further studies are needed (e.g. in carriers).